These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 20594986

  • 21. [Oropharyngeal candidiasis in elderly patients].
    Laurent M, Gogly B, Tahmasebi F, Paillaud E.
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Mar; 9(1):21-8. PubMed ID: 21586373
    [Abstract] [Full Text] [Related]

  • 22. [Progressive resistance to fluconazole in a patient with HIV infection and recurrent oropharyngeal candidiasis].
    Corzo Delgado JE, Lozano de León F, Aretio Najarro R, Martín Mazuelos E.
    Med Clin (Barc); 1994 Nov 12; 103(16):639. PubMed ID: 7996928
    [No Abstract] [Full Text] [Related]

  • 23. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
    Goldman M, Cloud GA, Wade KD, Reboli AC, Fichtenbaum CJ, Hafner R, Sobel JD, Powderly WG, Patterson TF, Wheat LJ, Stein DK, Dismukes WE, Filler SG, AIDS Clinical Trials Group Study Team 323, Mycoses Study Group Study Team 40.
    Clin Infect Dis; 2005 Nov 15; 41(10):1473-80. PubMed ID: 16231260
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies.
    Epstein JB, Polsky B.
    Clin Ther; 1998 Nov 15; 20(1):40-57. PubMed ID: 9522103
    [Abstract] [Full Text] [Related]

  • 26. Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial.
    Corvò R, Amichetti M, Ascarelli A, Arcangeli G, Buffoli A, Cellini N, Cionini L, De Renzis C, Emiliani E, Franchini P, Gabriele P, Gobitti C, Grillo Ruggieri F, Bertoni F, Magrini SM, Marmiroli L, Orsatti M, Panizza GM, Tordiglione M, Ziccarelli L, Gava A, Zorat PL, Ghelfi R, Serra GF, Vitale V.
    Eur J Cancer Care (Engl); 2008 May 15; 17(3):270-7. PubMed ID: 18419630
    [Abstract] [Full Text] [Related]

  • 27. Oropharyngeal candidiasis in AIDS patients from Abidjan (Ivory Coast): antifungal susceptibilities and multilocus enzyme electrophoresis analysis of Candida albicans isolates.
    Nébavi F, Arnavielhe S, Le Guennec R, Ménan E, Kacou A, Combe P, Aoussi E, Mallié M, Koné M, Bastide JM.
    Pathol Biol (Paris); 1998 May 15; 46(5):307-14. PubMed ID: 9769890
    [Abstract] [Full Text] [Related]

  • 28. Fluconazole-resistant pseudomembranous oral candidiasis.
    Shetty K.
    Ann Pharmacother; 2006 May 15; 40(5):993. PubMed ID: 16638917
    [No Abstract] [Full Text] [Related]

  • 29. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
    Hamza OJ, Matee MI, Brüggemann RJ, Moshi MJ, Simon EN, Mugusi F, Mikx FH, van der Lee HA, Verweij PE, van der Ven AJ.
    Clin Infect Dis; 2008 Nov 15; 47(10):1270-6. PubMed ID: 18840077
    [Abstract] [Full Text] [Related]

  • 30. A systematic review of oral fungal infections in patients receiving cancer therapy.
    Lalla RV, Latortue MC, Hong CH, Ariyawardana A, D'Amato-Palumbo S, Fischer DJ, Martof A, Nicolatou-Galitis O, Patton LL, Elting LS, Spijkervet FK, Brennan MT, Fungal Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO).
    Support Care Cancer; 2010 Aug 15; 18(8):985-92. PubMed ID: 20449755
    [Abstract] [Full Text] [Related]

  • 31. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
    Belazi M, Velegraki A, Koussidou-Eremondi T, Andreadis D, Hini S, Arsenis G, Eliopoulou C, Destouni E, Antoniades D.
    Oral Microbiol Immunol; 2004 Dec 15; 19(6):347-51. PubMed ID: 15491459
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs.
    Lim SG, Lee CA, Hales M, O'Doherty M, Winter M, Kernoff PB.
    Aliment Pharmacol Ther; 1991 Apr 15; 5(2):199-205. PubMed ID: 1888820
    [Abstract] [Full Text] [Related]

  • 34. [Fluconazole in oro-pharyngeal candidiasis in retroviral infection (experience in Dakar)].
    Sow PS, Diop BM, Ndiaye I, Faye MA, Coll-Seck AM.
    Dakar Med; 1993 Apr 15; 38(1):85-8. PubMed ID: 7882856
    [Abstract] [Full Text] [Related]

  • 35. Fluconazole found effective against candidiasis.
    Oncology (Williston Park); 1989 Nov 15; 3(11):112. PubMed ID: 2561879
    [No Abstract] [Full Text] [Related]

  • 36. An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.
    Oude Lashof AM, De Bock R, Herbrecht R, de Pauw BE, Krcmery V, Aoun M, Akova M, Cohen J, Siffnerová H, Egyed M, Ellis M, Marinus A, Sylvester R, Kullberg BJ, EORTC Invasive Fungal Infections Group.
    Eur J Cancer; 2004 Jun 15; 40(9):1314-9. PubMed ID: 15177489
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.